Skip to main content

Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT)

Publication ,  Conference
Solanki, AA; Bitting, R; Campbell, D; Carlson, K; Garraway, I; Henry, E; Johnson, M; Jones, J; Koppes, T; Quek, M; Rettig, M; Ritter, TA ...
Published in: Cancer Research
April 25, 2025

Duke Scholars

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 25, 2025

Volume

85

Issue

8_Supplement_2

Start / End Page

CT254 / CT254

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Solanki, A. A., Bitting, R., Campbell, D., Carlson, K., Garraway, I., Henry, E., … Nickols, N. G. (2025). Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). In Cancer Research (Vol. 85, pp. CT254–CT254). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2025-ct254
Solanki, Abhishek A., Rhonda Bitting, Dara Campbell, Kimberly Carlson, Isla Garraway, Elizabeth Henry, Michelle Johnson, et al. “Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT).” In Cancer Research, 85:CT254–CT254. American Association for Cancer Research (AACR), 2025. https://doi.org/10.1158/1538-7445.am2025-ct254.
Solanki AA, Bitting R, Campbell D, Carlson K, Garraway I, Henry E, et al. Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). In: Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT254–CT254.
Solanki, Abhishek A., et al. “Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT).” Cancer Research, vol. 85, no. 8_Supplement_2, American Association for Cancer Research (AACR), 2025, pp. CT254–CT254. Crossref, doi:10.1158/1538-7445.am2025-ct254.
Solanki AA, Bitting R, Campbell D, Carlson K, Garraway I, Henry E, Johnson M, Jones J, Koppes T, Quek M, Rettig M, Ritter TA, Robin L, Salama JK, Skipworth A, Zachny E, Zheng K, Nickols NG. Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT254–CT254.

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 25, 2025

Volume

85

Issue

8_Supplement_2

Start / End Page

CT254 / CT254

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis